Venomyx Therapeutics

📍 La Jolla, United States🗓 Founded 2015👥 1 employees💰 Last funded 2019
Biotechnology🌐 venomyx.com
Website LinkedIn
Venomyx is bringing antivenom into the 21st century with the world's first toxin-specific snake antivenom. Our solution will make antivenom treatment safe, effective, and affordable for the millions of snakebite victims per year around the world. We participated in SF-based IndieBio, world's largest seed biotech accelerator. We are currently developing and conducting preclinical studies on our therapeutic candidates.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Indonesia
1
Frequently asked questions
Who invested in Venomyx Therapeutics?
Venomyx Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Venomyx Therapeutics last raise funding?
The most recent investment in Venomyx Therapeutics recorded on gritt.io was in 2019.
When was Venomyx Therapeutics founded?
Venomyx Therapeutics was founded in 2015.
What industry is Venomyx Therapeutics in?
Venomyx Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Venomyx Therapeutics based?
Venomyx Therapeutics is headquartered in La Jolla, United States.